Click on the link for the NEJM Journal Watch weekly update. Another good week for SARS-CoV-2 articles. Sorry for the late post but I was out of town…
https://www.jwatch.org/fw117582/2021/03/06/latest-covid-19-news-week-ending-mar-6-2021
Meanwhile in Clarksdale Mississippi…
REMAIN VIGILANT.
Click on the link for the NEJM Journal Watch weekly update. One hell of a great week for SARS-CoV-2 articles.
https://www.jwatch.org/fw117559/2021/02/27/latest-covid-19-news-week-ending-feb-27-2021
Meanwhile at the NIH/NIC…
People who have had evidence of a prior infection with SARS-CoV-2, the virus that causes COVID-19, appear to be well protected against being reinfected with the virus, at least for a few months, according to a newly published study from the National Cancer Institute (NCI).
NIH study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection – https://www.nih.gov/news-events/news-releases/nih-study-finds-people-sars-cov-2-antibodies-may-have-low-risk-future-infection
A few days ago I used the Bird Button to tweet a link to a JWatch article. Today I decided to embed my previous tweet to see what it looks like on the blog.
Embedment is an easy way to blog. Looks good too.
I’ve been having a lot of fun since learning how to embed a Bird App Tweet into my posts.
Vaccines shift the age distribution of the critically ill from SARS-CoV-2 to younger ages in the preliminary data from Israel. This is no time to let your guard down. Stay safe and get vaccinated as soon as you can.
In Israel, people who are 60 years and older were prioritized to get the vaccine first. When we analyze that group, we see that since the peak in mid-January, there’s now a 55% reduction in cases, 40% reduction in hospitalizations, 35% reduction in critically ill patients, and also now even a 35% reduction in mortality in that age group.
‘The Impact of the Vaccine Has Been Tremendous’ Medscape – Feb 17, 2021. — https://www.medscape.com/viewarticle/945680#vp_2
You must be logged in to post a comment.